Literature DB >> 20541168

Practical considerations for planning a therapeutic apheresis procedure.

Suresh G Shelat1.   

Abstract

The general medicine and critical care services often care for patients that require therapeutic apheresis. Apheresis procedures are performed for various hematologic, neurological, renal, autoimmune, metabolic, and other indications. To facilitate a prompt start to the procedure, the clinical team must coordinate efforts with several services, including those that perform the apheresis procedure, establish venous access, and provide blood or replacement products, in addition to the pharmacy and clinical laboratory. Some of these tasks are performed typically by the clinical teams, while others are performed typically by the apheresis team. Presented and discussed are the indications for therapeutic apheresis, calculations for the ordering of blood products, and several important and practical details to consider, thus preventing delays in starting the apheresis procedure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541168     DOI: 10.1016/j.amjmed.2010.01.022

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.

Authors:  Sherif Hanafy Mahmoud; Jessica Buhler; Eric Chu; Suzie A Chen; Theresa Human
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

2.  Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.

Authors:  Rory M Shallis; Maximilian Stahl; Wei Wei; Pau Montesinos; Etienne Lengline; Judith Neukirchen; Vijaya R Bhatt; Mikkael A Sekeres; Amir T Fathi; Heiko Konig; Selina Luger; Irum Khan; Gail J Roboz; Thomas Cluzeau; David Martínez-Cuadron; Emmanuel Raffoux; Ulrich Germing; Jayadev Manikkam Umakanthan; Sudipto Mukhereje; Andrew M Brunner; Adam Miller; Christine M McMahon; Ellen K Ritchie; Rebeca Rodríguez-Veiga; Raphaël Itzykson; Blanca Boluda; Florence Rabian; Mar Tormo; Evelyn Acuña-Cruz; Emma Rabinovich; Brendan Yoo; Isabel Cano; Nikolai A Podoltsev; Jan Philipp Bewersdorf; Steven Gore; Amer M Zeidan
Journal:  Leuk Lymphoma       Date:  2020-02-26

3.  A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia.

Authors:  Yanxia Jin; Shishang Guo; Qin Cui; Sichao Chen; Xiaoping Liu; Yongchang Wei; Yunbao Pan; Liang Tang; Tingting Huang; Hui Shen; Guanghui Xu; Xuelan Zuo; Shangqin Liu; Hui Xiao; Fei Chen; Fayun Gong; Fuling Zhou
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

4.  Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations.

Authors:  Ian Baldwin; Sarah Todd
Journal:  J Clin Apher       Date:  2022-04-06       Impact factor: 2.605

5.  Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.

Authors:  Ikhwan Rinaldi; Resti Mulya Sari; Vanya Utami Tedhy; Kevin Winston
Journal:  J Blood Med       Date:  2021-07-14

6.  Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Authors:  Yahsou Delmas; Benoît Vendrely; Benjamin Clouzeau; Hiba Bachir; Hoang-Nam Bui; Adeline Lacraz; Sébastien Hélou; Cécile Bordes; Armel Reffet; Brigitte Llanas; Sophie Skopinski; Patrick Rolland; Didier Gruson; Christian Combe
Journal:  Nephrol Dial Transplant       Date:  2013-11-28       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.